Quarterly report [Sections 13 or 15(d)]

Business Combination (Details)

v3.26.1
Business Combination (Details) - USD ($)
Oct. 07, 2024
Jun. 30, 2026
Jun. 16, 2026
Business Combination      
Preferred stock, par value (in dollars per share)   $ 0.0001 $ 0.0001
Pharmagesic      
Business Combination      
Percentage of shares acquired 100.00%    
Maximum percentage issued 19.99%    
Preferred stock, par value (in dollars per share) $ 0.0001    
Number of shares of common issuable for each preferred share 10,000    
Total Consideration Paid $ 71,265,727    
Pharmagesic | Common stock      
Business Combination      
Number of shares issued 211,383    
Pharmagesic | Series A Non-Voting Convertible Preferred Stock      
Business Combination      
Number of shares issued 2,108.3854